Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Lab Invest ; 104(1): 100262, 2024 01.
Article in English | MEDLINE | ID: mdl-37839639

ABSTRACT

With advancements in the field of digital pathology, there has been a growing need to compare the diagnostic abilities of pathologists using digitized whole slide images against those when using traditional hematoxylin and eosin (H&E)-stained glass slides for primary diagnosis. One of the most common specimens received in pathology practices is an endoscopic gastric biopsy with a request to rule out Helicobacter pylori (H. pylori) infection. The current standard of care is the identification of the organisms on H&E-stained slides. Immunohistochemical or histochemical stains are used selectively. However, due to their small size (2-4 µm in length by 0.5-1 µm in width), visualization of the organisms can present a diagnostic challenge. The goal of the study was to compare the ability of pathologists to identify H. pylori on H&E slides using a digital platform against the gold standard of H&E glass slides using routine light microscopy. Diagnostic accuracy rates using glass slides vs digital slides were 81% vs 72% (P = .0142) based on H&E slides alone. When H. pylori immunohistochemical slides were provided, the diagnostic accuracy was significantly improved to comparable rates (96% glass vs 99% digital, P = 0.2199). Furthermore, differences in practice settings (academic/subspecialized vs community/general) and the duration of sign-out experience did not significantly impact the accuracy of detecting H. pylori on digital slides. We concluded that digital whole slide images, although amenable in different practice settings and teaching environments, does present some shortcomings in accuracy and precision, especially in certain circumstances and thus is not yet fully capable of completely replacing glass slide review for identification of H. pylori. We specifically recommend reviewing glass slides and/or performing ancillary stains, especially when there is a discrepancy between the degree of inflammation and the presence of microorganisms on digital images.


Subject(s)
Helicobacter pylori , Hematoxylin , Eosine Yellowish-(YS) , Coloring Agents , Microscopy/methods
2.
Ann Surg Oncol ; 16(8): 2331-8, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19434452

ABSTRACT

BACKGROUND: Loss of expression of fragile gene products, Fhit and Wwox, occurs in many cancer types, with loss exhibited early in the neoplastic process in some. Wwox has been understudied in pancreatobiliary cancers, especially in relation to other involved tumor suppressors. We have assessed the status of the Fhit and Wwox proteins encoded by DNA damage susceptible chromosome fragile sites encompassed by FHIT and WWOX tumor suppressor genes. METHODS: Pancreatic, gallbladder and ampullary cancers, normal pancreas, chronic pancreatitis, and benign gallbladder specimens were stained for expression of Fhit, Fhit effector protein Fdxr, Wwox, and other tumor suppressors by immunohistochemistry, and comparisons were made between benign and malignant tissue. Correlations of expression among proteins and clinicopathologic features were sought using Spearman's rank order. Survival curves were created using the Kaplan-Meier method and compared by log-rank analysis. Predictors of survival were determined using multivariate Cox proportional hazards analysis. RESULTS: Fhit and Wwox were ubiquitously expressed in benign samples and significantly and coordinately reduced in pancreatic, gallbladder, and ampullary cancers. In pancreatic cancers, Fdxr expression was positively correlated with Fhit and Wwox expression. Neither Fhit nor Wwox expression correlated with expression of other tumor suppressors or with clinicopathologic characteristics measured. CONCLUSION: Loss of Fhit and Wwox expression does not predict tumor progression or patient survival, suggesting that loss of expression of genes at the exquisitely replication stress sensitive chromosome fragile regions is an early event in the pathogenesis of cancers of the gallbladder, pancreas, and ampulla.


Subject(s)
Acid Anhydride Hydrolases/metabolism , Ampulla of Vater/metabolism , Common Bile Duct Neoplasms/metabolism , Gallbladder Neoplasms/metabolism , Gene Expression Regulation, Neoplastic/physiology , Neoplasm Proteins/metabolism , Oxidoreductases/metabolism , Pancreatic Neoplasms/metabolism , Tumor Suppressor Proteins/metabolism , Acid Anhydride Hydrolases/genetics , Aged , Ampulla of Vater/pathology , Common Bile Duct Neoplasms/pathology , Female , Gallbladder Neoplasms/pathology , Humans , Immunoenzyme Techniques , Male , Middle Aged , Neoplasm Proteins/genetics , Neoplasms/metabolism , Neoplasms/pathology , Oxidoreductases/genetics , Pancreatic Neoplasms/pathology , Prognosis , Survival Rate , Tissue Array Analysis , Tumor Suppressor Proteins/genetics , WW Domain-Containing Oxidoreductase
3.
Laryngoscope ; 115(8): 1461-2, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16094125

ABSTRACT

OBJECTIVES/HYPOTHESIS: Described is the first reported case of an angiofibrolipoma of the ear canal in a patient who presented with right-sided conductive hearing loss and a medial canal stenosis. STUDY DESIGN: Case report. RESULTS/CONCLUSION: This variant of lipoma contains mature adipocytes, blood vessels, and dense collagenous tissue. The physical examination can be misleading, and the diagnosis requires histopathological examination. The patient was treated with complete surgical excision, tympanoplasty, canalplasty, and skin grafting to the external auditory canal. His pure-tone average improved from 37 to 11 dB, and his air-bone gap was closed completely. The lipoma has not recurred in the 6-month period following surgery.


Subject(s)
Angiofibroma/pathology , Ear Canal/physiopathology , Ear Neoplasms/pathology , Hearing Loss, Conductive/diagnosis , Hearing Loss, Conductive/etiology , Otolaryngology/methods , Adult , Angiofibroma/complications , Angiofibroma/surgery , Biopsy, Needle , Ear Neoplasms/complications , Ear Neoplasms/surgery , Follow-Up Studies , Humans , Immunohistochemistry , Magnetic Resonance Imaging/methods , Male , Risk Assessment , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...